Law360, Chicago (December 9, 2013, 7:32 PM EST) -- An Illinois federal judge on Monday slapped Boehringer Ingelheim Pharmaceuticals Inc. with nearly $1 million in sanctions for discovery abuses in multidistrict litigation over its oral anticoagulant Pradaxa, finding that the drugmaker's failure to produce thousands of documents amounted to bad-faith conduct.
BIPI, along with German parent Boehringer Ingelheim International GmbH, can't explain away their failure to enact a companywide litigation hold to preserve critical documents and communications by June 2012, when they knew a wave of product liability lawsuits over Pradaxa was inevitable, according to an order signed by U.S. District Judge David R. Herndon.
Noting that the court has...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!